Singapore, July 8 -- RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for cells, bioprocess media and recombinant growth factors. The... Read More
Singapore, July 8 -- Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and commercial supply of MCO-010, Nanoscope's lead optogenetic gene ... Read More
Singapore, July 8 -- FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical trial in patients with diabetic foot ulcers. The batch wa... Read More
Singapore, July 7 -- Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and supply agreement with Orion Corporation, a globally operat... Read More
Singapore, July 7 -- South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has signed a supply agreement with Raffles Medical for i... Read More
Singapore, July 7 -- Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsidiary Alvogen Korea has commenced distribution of Uro-Vaxom... Read More
Singapore, July 6 -- China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the official signing of a strategic cooperation agreement. This par... Read More
Singapore, July 6 -- University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing collaboration in drug discovery and development for five m... Read More
Singapore, July 6 -- Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine hybrid candidates. Under the agreement, Matica Bio will p... Read More
Singapore, July 6 -- Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates ASC36 and ASC36_35 FDC. ASC36 is a next-generation peptid... Read More